These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1768 related items for PubMed ID: 8262682

  • 1. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P, Schøller J, Hou-Jensen K, Zeuthen J.
    Int J Cancer; 1994 Jan 02; 56(1):78-86. PubMed ID: 8262682
    [Abstract] [Full Text] [Related]

  • 2. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J, Birck A, Straten PT.
    Arch Immunol Ther Exp (Warsz); 1995 Jan 02; 43(2):123-33. PubMed ID: 8744727
    [Abstract] [Full Text] [Related]

  • 3. An analysis of T-cell-receptor variable-region genes in tumor-infiltrating lymphocytes within malignant tumors.
    Nitta T, Sato K, Okumura K, Steinman L.
    Int J Cancer; 1991 Oct 21; 49(4):545-50. PubMed ID: 1655662
    [Abstract] [Full Text] [Related]

  • 4. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 5. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
    Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril MF, Hercend T.
    J Clin Invest; 1993 Mar 01; 91(3):1183-90. PubMed ID: 8450047
    [Abstract] [Full Text] [Related]

  • 6. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
    Schøller J, thor Straten P, Birck A, Siim E, Dahlström K, Drzewiecki KT, Zeuthen J.
    Cancer Immunol Immunother; 1994 Oct 01; 39(4):239-48. PubMed ID: 7954526
    [Abstract] [Full Text] [Related]

  • 7. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL.
    Int J Cancer; 1993 May 28; 54(3):383-90. PubMed ID: 8509212
    [Abstract] [Full Text] [Related]

  • 8. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ, Weil DP, Shamamian P, Rivoltini L, Kawakami Y, Topalian S, Jennings C, Eliyahu S, Rosenberg SA, Nishimura MI.
    Cancer Res; 1994 Oct 15; 54(20):5265-8. PubMed ID: 7522957
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
    Nishimura MI, Kawakami Y, Charmley P, O'Neil B, Shilyansky J, Yannelli JR, Rosenberg SA, Hood L.
    J Immunother Emphasis Tumor Immunol; 1994 Aug 15; 16(2):85-94. PubMed ID: 7804531
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.
    Nitta T, Oksenberg JR, Rao NA, Steinman L.
    Science; 1990 Aug 10; 249(4969):672-4. PubMed ID: 2382141
    [Abstract] [Full Text] [Related]

  • 13. T-cell receptor V beta gene expression differs in tumor-infiltrating lymphocytes within primary and metastatic melanoma.
    Nitta T, Bell R, Okumura K, Sato K, Steinman L.
    Cancer Res; 1991 Oct 15; 51(20):5565-9. PubMed ID: 1655255
    [Abstract] [Full Text] [Related]

  • 14. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
    Shilyansky J, Nishimura MI, Yannelli JR, Kawakami Y, Jacknin LS, Charmley P, Rosenberg SA.
    Proc Natl Acad Sci U S A; 1994 Mar 29; 91(7):2829-33. PubMed ID: 7511820
    [Abstract] [Full Text] [Related]

  • 15. Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes.
    Sensi M, Castelli C, Salvi S, Mazzocchi A, Mortarini R, Nicolini G, Anichini A, Parmiani G.
    J Immunother (1991); 1992 Oct 29; 12(3):207-11. PubMed ID: 1332745
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
    Yazdi AS, Morstedt K, Puchta U, Ghoreschi K, Flaig MJ, Rocken M, Sander CA.
    J Invest Dermatol; 2006 Feb 29; 126(2):393-8. PubMed ID: 16374454
    [Abstract] [Full Text] [Related]

  • 17. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.
    Cancer Res; 1997 Dec 01; 57(23):5320-7. PubMed ID: 9393756
    [Abstract] [Full Text] [Related]

  • 18. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.
    thor Straten P, Becker JC, Seremet T, Bröcker EB, Zeuthen J.
    J Clin Invest; 1996 Jul 15; 98(2):279-84. PubMed ID: 8755635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P, Schøller J, Hou-Jensen K, Zeuthen J.
    Int J Cancer; 1994 Apr 01; 57(1):138. PubMed ID: 8150534
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 89.